Karen Breen

1.5k total citations
47 papers, 808 citations indexed

About

Karen Breen is a scholar working on Internal Medicine, Hematology and Rheumatology. According to data from OpenAlex, Karen Breen has authored 47 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Internal Medicine, 17 papers in Hematology and 15 papers in Rheumatology. Recurrent topics in Karen Breen's work include Venous Thromboembolism Diagnosis and Management (22 papers), Systemic Lupus Erythematosus Research (14 papers) and Central Venous Catheters and Hemodialysis (9 papers). Karen Breen is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (22 papers), Systemic Lupus Erythematosus Research (14 papers) and Central Venous Catheters and Hemodialysis (9 papers). Karen Breen collaborates with scholars based in United Kingdom, Denmark and United States. Karen Breen's co-authors include Beverley J. Hunt, David Grimwade, Kiran Parmar, Gary Moore, Paul T. Seed, Peter O’Gorman, Conor Shortt, Martin J. O’Connell, John C. McHugh and Tadhg G. Gleeson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Critical Care Medicine.

In The Last Decade

Karen Breen

40 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Breen United Kingdom 14 338 238 186 156 148 47 808
Alejandro Olivé Spain 14 216 0.6× 246 1.0× 383 2.1× 126 0.8× 354 2.4× 77 1.1k
Shayna Sarosiek United States 16 247 0.7× 87 0.4× 210 1.1× 545 3.5× 114 0.8× 109 1.1k
H. Desmurs‐Clavel France 12 201 0.6× 113 0.5× 230 1.2× 69 0.4× 119 0.8× 21 832
Kazuo Kawasugi Japan 15 358 1.1× 122 0.5× 258 1.4× 61 0.4× 148 1.0× 69 944
Gili Kenet Israel 20 762 2.3× 63 0.3× 116 0.6× 79 0.5× 135 0.9× 72 1.1k
Eleftheria Lefkou Greece 13 202 0.6× 150 0.6× 80 0.4× 51 0.3× 77 0.5× 48 650
Maria T. DeSancho United States 15 261 0.8× 109 0.5× 247 1.3× 47 0.3× 140 0.9× 52 716
Michel Pavic France 14 121 0.4× 71 0.3× 75 0.4× 146 0.9× 113 0.8× 96 901
Payal M. Patel United States 11 67 0.2× 92 0.4× 189 1.0× 42 0.3× 129 0.9× 36 673
Taru Hays United States 20 831 2.5× 62 0.3× 258 1.4× 119 0.8× 234 1.6× 42 1.2k

Countries citing papers authored by Karen Breen

Since Specialization
Citations

This map shows the geographic impact of Karen Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Breen more than expected).

Fields of papers citing papers by Karen Breen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Breen. The network helps show where Karen Breen may publish in the future.

Co-authorship network of co-authors of Karen Breen

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Breen. A scholar is included among the top collaborators of Karen Breen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Breen. Karen Breen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arachchillage, Deepa J., Sean Platton, Justin Chu, et al.. (2024). Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology. 205(3). 855–880. 12 indexed citations
3.
4.
Doyle, Andrew J., et al.. (2024). The Efficacy and Safety of DOACs in Inherited Antithrombin Deficiency: A Cohort Study from a Tertiary Referral Center. Thrombosis and Haemostasis. 125(4). 379–384. 2 indexed citations
5.
Stafford, Andrew, et al.. (2023). Bleeding related hospitalizations and mortality in England 2014–2019. Journal of Thrombosis and Thrombolysis. 56(2). 233–240. 1 indexed citations
6.
Patel, Sajal M., et al.. (2023). Interventional therapies in acute pulmonary embolus—current trends and future directions. British Journal of Radiology. 96(1149). 20221151–20221151. 1 indexed citations
7.
Breen, Karen, et al.. (2023). Nitrous oxide misuse: a clue not to be missed in young patients with venous thromboembolism. Clinical Medicine. 23(2). 170–172. 3 indexed citations
8.
Breen, Karen, et al.. (2023). PB0436 Long-Term Use of Fondaparinux in Patients with Thrombotic Antiphospholipid Syndrome - A Retrospective Audit of Clinical Outcomes. Research and Practice in Thrombosis and Haemostasis. 7. 101707–101707.
9.
Curto‐García, Natalia, Andrew J. Doyle, Karen Breen, et al.. (2020). Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm‐associated venous thromboembolism in a large tertiary centre in the UK. British Journal of Haematology. 189(3). e79–e81. 23 indexed citations
10.
Gwozdz, Adam, Andrew J. Doyle, Beverley J. Hunt, et al.. (2020). Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(4). 888–894. 5 indexed citations
11.
Doyle, Andrew J., Joel Meyer, Karen Breen, & Beverley J. Hunt. (2020). N‐Methyl‐3,4‐methylendioxymethamphetamine (MDMA)‐related coagulopathy and rhabdomyolysis: A case series and literature review. Research and Practice in Thrombosis and Haemostasis. 4(5). 829–834. 7 indexed citations
12.
Doyle, Andrew J., Karen Breen, Donal P. McLornan, et al.. (2019). Outcomes of Patients Receiving Direct Oral Anticoagulants for Myeloproliferative Neoplasm Associated Venous Thromboembolism. Blood. 134(Supplement_1). 4183–4183. 3 indexed citations
13.
Pouncey, Anna Louise, Adam Gwozdz, Oscar W. Johnson, et al.. (2019). Midterm outcomes in postpartum women following endovenous treatment for acute iliofemoral deep vein thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 8(2). 167–173. 4 indexed citations
14.
Black, Stephen, Adam Gwozdz, Narayan Karunanithy, et al.. (2018). Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent®. European Journal of Vascular and Endovascular Surgery. 56(5). 710–718. 58 indexed citations
15.
Schreiber, Karen, Karen Breen, Kiran Parmar, et al.. (2017). The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. Lara D. Veeken. 57(1). 120–124. 41 indexed citations
16.
Saha, Prakash, Stephen Black, Karen Breen, et al.. (2016). Contemporary management of acute and chronic deep venous thrombosis. British Medical Bulletin. 117(1). 107–120. 23 indexed citations
17.
McDonald, Vickie, et al.. (2015). Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism?. Thrombosis Research. 136(6). 1332–1333. 1 indexed citations
18.
Breen, Karen, et al.. (2014). Endothelial and platelet microparticles in patients with antiphospholipid antibodies. Thrombosis Research. 135(2). 368–374. 41 indexed citations
19.
Breen, Karen, David Grimwade, & Beverley J. Hunt. (2011). The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia. British Journal of Haematology. 156(1). 24–36. 87 indexed citations
20.
Breen, Karen, et al.. (2000). One Hundred Books That Shaped the Century.. School library journal. 46(1). 50–58. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Olivé Breakdown of academic impact, for papers by Shayna Sarosiek Breakdown of academic impact, for papers by H. Desmurs‐Clavel Breakdown of academic impact, for papers by Kazuo Kawasugi Breakdown of academic impact, for papers by Gili Kenet Breakdown of academic impact, for papers by Eleftheria Lefkou Breakdown of academic impact, for papers by Maria T. DeSancho Breakdown of academic impact, for papers by Michel Pavic Breakdown of academic impact, for papers by Payal M. Patel Breakdown of academic impact, for papers by Taru Hays
Rankless by CCL
2026